{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:56:56Z","timestamp":1792821416283,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.eimc.2014.03.010","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T11:15:44Z","timestamp":1402139744000},"page":"248-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Emergence of quinolone-resistant, topoisomerase-mutant Brucella after treatment with fluoroquinolones in a macrophage experimental infection model"],"prefix":"10.1016","volume":"33","author":[{"given":"Elisa","family":"Rodr\u00edguez Tarazona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Garc\u00eda Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Mu\u00f1oz Bellido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2014.03.010_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-117-1-25","article-title":"Treatment of human brucellosis with doxycycline plus rifampicin or doxycycline plus streptomycin: a randomized, double-blind study","volume":"17","author":"Ariza","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2014.03.010_bib0010","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1128\/AAC.39.9.2061","article-title":"Doxycycline\u2013rifampin versus doxycycline\u2013streptomycin in treatment of human brucellosis due to Brucella melitensis","volume":"39","author":"Solera","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.03.010_bib0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199607000-00003","article-title":"Complications associated with Brucella melitensis infections: a study of 530 cases","volume":"75","author":"Colmenero","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2014.03.010_bib0020","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinids\/20.5.1241","article-title":"Characteristics of and risk factors for relapse of brucellosis in humans","volume":"20","author":"Ariza","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.03.010_bib0025","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1128\/AAC.33.8.1409","article-title":"Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis","volume":"33","author":"Khan","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.03.010_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.36.1.150","article-title":"Efficacy of ciprofloxacin for treatment of Brucella melitensis infections","volume":"36","author":"al-Sibai","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.03.010_bib0035","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/AAC.39.5.1194","article-title":"Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones","volume":"39","author":"Garc\u00eda-Rodr\u00edguez","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.03.010_bib0040","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/AAC.43.9.2337","article-title":"Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis","volume":"43","author":"G\u00fcr","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.03.010_bib0045","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.43.5.1298","article-title":"In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs","volume":"43","author":"Akova","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.03.010_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.35.1.88","article-title":"In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin","volume":"35","author":"Raoult","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.03.010_bib0055","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1128\/AAC.36.11.2529","article-title":"Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin","volume":"36","author":"Jabarit-Aldighieri","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.03.010_bib0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijantimicag.2008.03.012","article-title":"In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA","volume":"32","author":"Turkmani","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2014.03.010_bib0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijantimicag.2008.12.013","article-title":"Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro","volume":"34","author":"Garc\u00eda L\u00e1zaro","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2014.03.010_bib0070","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard\u2014Ninth Edition. CLSI document M07-A9","author":"Clinical Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.eimc.2014.03.010_bib0075","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1128\/IAI.65.8.3186-3192.1997","article-title":"Intracellular Salmonella dublin induces substantial secretion of the 40-kilodalton subunit of interleukin-12 (IL-12) but minimal secretion of IL-12 as a 70-kilodalton protein in murine macrophages","volume":"65","author":"Bost","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.eimc.2014.03.010_bib0080","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0923-2508(91)90007-W","article-title":"Characterization of smooth Brucella lipopolysaccharides and polysaccharides by monoclonal antibodies","volume":"142","author":"Vizcaino","year":"1991","journal-title":"Res Microbiol"},{"key":"10.1016\/j.eimc.2014.03.010_bib0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0076-6879(94)36030-8","article-title":"Measurement of invasion by gentamicin resistance","volume":"236","author":"Elsinghorst","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.eimc.2014.03.010_bib0090","series-title":"Quinolonas. En Antimicrobianos en Medicina","first-page":"271","author":"Gobernado","year":"2006"},{"key":"10.1016\/j.eimc.2014.03.010_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00338386","article-title":"Quinolone-resistant mutations of the gyrA gene of Escherichia coli","volume":"211","author":"Yoshida","year":"1988","journal-title":"Mol Gen Genet"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X14001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X14001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T18:21:52Z","timestamp":1597947712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X14001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0213005X14001384"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2014.03.010","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of quinolone-resistant, topoisomerase-mutant Brucella after treatment with fluoroquinolones in a macrophage experimental infection model","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2014.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}